STEM CELL TRANSPLANTATION, HEMATOPOIETIC
Clinical trials for STEM CELL TRANSPLANTATION, HEMATOPOIETIC explained in plain language.
Never miss a new study
Get alerted when new STEM CELL TRANSPLANTATION, HEMATOPOIETIC trials appear
Sign up with your email to follow new studies for STEM CELL TRANSPLANTATION, HEMATOPOIETIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New transplant approach aims to beat back aggressive leukemia in young adults
Disease control Not yet recruitingThis trial tests a new way to do a stem cell transplant for young adults (ages 16-55) with very aggressive acute myeloid leukemia (AML) that hasn't responded to chemo or has high-risk gene changes. Instead of a standard transplant, patients receive umbilical cord blood plus extra…
Matched conditions: STEM CELL TRANSPLANTATION, HEMATOPOIETIC
Phase: PHASE1, PHASE2 • Sponsor: University of Manchester • Aim: Disease control
Last updated Apr 29, 2026 01:19 UTC
-
New study aims to predict CMV infections after stem cell transplants
Knowledge-focused Not yet recruitingThis study follows 123 stem cell transplant patients who received a drug called letermovir to prevent CMV infection. Researchers want to see if the immune system's recovery after stopping the drug can predict whether a late CMV infection will occur. The goal is to personalize how…
Matched conditions: STEM CELL TRANSPLANTATION, HEMATOPOIETIC
Sponsor: Maimónides Biomedical Research Institute of Córdoba • Aim: Knowledge-focused
Last updated Apr 29, 2026 01:20 UTC